On the other hand, GHRH antagonist treatment has been shown to result in a significant alteration of the outer retinal layer and worsened retinal morphology.17 Therefore, preserving cell survival may prevent NPDR progression. The gene discussed is GHRH; the disease is non-proliferative diabetic retinopathy.